DAEWOONG CO.,LTD Logo

DAEWOONG CO.,LTD

003090 | KO

Overview

Corporate Details

ISIN(s):
KR7003090008
LEI:
Country:
South Korea
Address:
경기 성남시 중원구 상대원동 223-23, 성남시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-15 00:00
Regulatory Filings
투자판단관련주요경영사항(자회사의 주요경영사항)
Korean 14.9 KB
2025-09-05 00:00
Regulatory Filings
투자판단관련주요경영사항(자회사의 주요경영사항)
Korean 9.0 KB
2025-08-14 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 3.7 MB
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 4.0 MB
2025-07-30 00:00
Regulatory Filings
투자판단관련주요경영사항(자회사의 주요경영사항)
Korean 9.5 KB
2025-06-02 00:00
Governance Information
기업지배구조보고서공시
Korean 708.5 KB
2025-05-16 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.7 KB
2025-05-16 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 162.0 KB
2025-05-16 00:00
Major Shareholding Notification
최대주주등소유주식변동신고서
Korean 58.0 KB
2025-05-15 00:00
Major Shareholding Notification
[기재정정]최대주주등소유주식변동신고서
Korean 54.8 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 2.1 MB
2025-05-14 00:00
Major Shareholding Notification
[기재정정]최대주주등소유주식변동신고서
Korean 60.7 KB
2025-04-16 00:00
Capital/Financing Update
단기차입금증가결정(자회사의 주요경영사항)
Korean 11.5 KB
2025-04-02 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.0 KB
2025-04-01 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 62.4 KB

Automate Your Workflow. Get a real-time feed of all DAEWOONG CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DAEWOONG CO.,LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DAEWOONG CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CORCEPT THERAPEUTICS INC Logo
Develops and commercializes cortisol-modulating drugs for severe disorders like Cushing's syndrome.
United States of America
CORT
Corline Biomedical AB Logo
Develops heparin-based coatings for medical device biocompatibility and regenerative medicine.
Sweden
CLBIO
CorMedix Inc. Logo
Develops a catheter lock solution to prevent bloodstream infections in hemodialysis patients.
United States of America
CRMD
Corvus Pharmaceuticals, Inc. Logo
Develops novel, targeted therapies for immune diseases and cancer.
United States of America
CRVS
Cosma Spolka Akcyjna Logo
Produces natural hemp supplements and pharmaceutical raw materials for retail & wholesale markets.
Poland
COS
COSMO Pharmaceuticals N.V. Logo
Specialty pharma for gastroenterology/dermatology, offering colon treatments & manufacturing services.
Netherlands
COPN
Cosmos Health Inc. Logo
A global healthcare firm developing & distributing nutraceuticals, generics, and OTC medications.
United States of America
COSM
Coya Therapeutics, Inc. Logo
Developing Treg-modulating therapies for neurodegenerative and autoimmune diseases.
United States of America
COYA
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. Logo
Biotech firm developing cell therapies for regenerative medicine and immunotherapy applications.
United States of America
CELZ
CRESCENT BIOPHARMA, INC. Logo
A biotech company developing bispecific antibody therapies to treat solid tumors.
United States of America
CBIO

Talk to a Data Expert

Have a question? We'll get back to you promptly.